Clinical trial
The Incidence of Thromboembolic Events in Patients With Antibodies to Heparin-PF4 After Cardiac Bypass
NCT00237328 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Incidence of Thromboembolic Events in Patients With Antibodies to Heparin-PF4 After Cardiac Bypass
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- July 31, 2012
- Enrollment
- 1,015 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.